Designing new antimicrobial peptides to fight bacterial infections
Precision Design of Antimicrobial Peptides Against Bacterial Infections
This study is working on creating new types of treatments called antimicrobial peptides to help fight infections caused by bacteria that don't respond to regular antibiotics, using smart technology to find the best options while keeping them safe for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Purdue University NIH-funded |
| Lab location | 1 site (West Lafayette, United States) |
| Project ID | NIH-10915026 on NIH RePORTER |
What this research studies
This research focuses on developing innovative antimicrobial peptides (AMPs) to combat antibiotic-resistant bacterial infections. By utilizing advanced techniques such as machine learning and peptide synthesis, the project aims to create effective and selective AMPs that target specific resistant pathogens while minimizing toxicity. The researchers are employing a generative adversarial network model to generate diverse AMP candidates, which will be tested for their antibacterial properties. This approach seeks to provide a new class of therapeutics that can complement existing antibiotics and address the growing challenge of antibiotic resistance.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria.
Not a fit: Patients with infections that are not caused by bacterial pathogens or those who do not have antibiotic-resistant infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments for bacterial infections that are currently difficult to manage due to antibiotic resistance.
How similar studies have performed: Other research has shown promise in using antimicrobial peptides as effective treatments, indicating that this approach has potential for success.
Where this research is happening
West Lafayette, United States
- Purdue University — West Lafayette, United States (Active)
Researchers
- Principal investigator: Li, Jianing — Purdue University
- Study coordinator: Li, Jianing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.